Login Register Cart 0
Generic placeholder image

Current Respiratory Medicine Reviews

Editor-in-Chief

ISSN (Print): 1573-398X
ISSN (Online): 1875-6387

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Intensive Care Unit Management of Right Heart Failure and Lung Transplantation for Pulmonary Hypertension

Author(s): Anna Beale, Sahideh Safavi and John Granton*

Volume 20, Issue 3, 2024

Published on: 25 January, 2024

Page: [243 - 260] Pages: 18

DOI: 10.2174/011573398X269419231213095516

Price: $65

Abstract

Pulmonary hypertension is associated with worse outcomes across systemic and cardiopulmonary conditions. Right ventricular (RV) dysfunction often leads to poor outcomes due to a progressive increase in RV afterload. Recognition and management of RV dysfunction are important to circumvent hospitalization and improve patient outcomes. Early recognition of patients at risk for RV failure is important to ensure that medical therapy is optimized and, where appropriate, referral for lung transplant assessment is undertaken. Patients initiated on parenteral prostanoids and those with persistent intermediate to high risk for poor outcomes should be referred. For patients with RV failure, identifying reversible causes should be a priority in conjunction with efforts to optimize RV preload and strategies to reduce RV afterload. Admission to a monitored environment where vasoactive medications can treat RV failure and its sequelae, such as renal dysfunction, is essential in patients with severe RV failure. Exit strategies need to be identified early on, with consideration and implementation of extracorporeal support for those in whom recovery or transplantation are viable options. Enlisting the skills and support of a palliative care team may improve the quality of life for patients with limited options and those with ongoing symptoms from heart failure in the face of medical treatments.

« Previous Next »
Graphical Abstract

[1]
Chang KY, Duval S, Badesch DB, et al. Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry. J Am Heart Assoc 2022; 11(9): e024969.
[http://dx.doi.org/10.1161/JAHA.121.024969] [PMID: 35475351]
[2]
Tonelli AR, Arelli V, Minai OA, et al. Causes and circumstances of death in pulmonary arterial hypertension. Am J Respir Crit Care Med 2013; 188(3): 365-9.
[http://dx.doi.org/10.1164/rccm.201209-1640OC] [PMID: 23600433]
[3]
Konstam MA, Kiernan MS, Bernstein D, et al. Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association. Circulation 2018; 137(20): e578-622.
[http://dx.doi.org/10.1161/CIR.0000000000000560] [PMID: 29650544]
[4]
Humbert M, Kovacs G, Hoeper MM, Badagliacca R, Berger RMF, Brida M, et al. ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG). Eur Heart J 2022; 2022: 2022.
[5]
Benza RL, Gomberg-Maitland M, Miller DP, et al. The REVEAL Registry risk score calculator in patients newly diagnosed with pulmonary arterial hypertension. Chest 2012; 141(2): 354-62.
[http://dx.doi.org/10.1378/chest.11-0676] [PMID: 21680644]
[6]
Hoeper MM, Granton J. Intensive care unit management of patients with severe pulmonary hypertension and right heart failure. Am J Respir Crit Care Med 2011; 184(10): 1114-24.
[http://dx.doi.org/10.1164/rccm.201104-0662CI] [PMID: 21700906]
[7]
Sztrymf B, Souza R, Bertoletti L, et al. Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension. Eur Respir J 2010; 35(6): 1286-93.
[http://dx.doi.org/10.1183/09031936.00070209] [PMID: 19897557]
[8]
Harjola VP, Mebazaa A, Čelutkienė J, et al. Contemporary management of acute right ventricular failure: A statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology. Eur J Heart Fail 2016; 18(3): 226-41.
[http://dx.doi.org/10.1002/ejhf.478] [PMID: 26995592]
[9]
Tongers J, Schwerdtfeger B, Klein G, et al. Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension. Am Heart J 2007; 153(1): 127-32.
[http://dx.doi.org/10.1016/j.ahj.2006.09.008] [PMID: 17174650]
[10]
Kucher N, Walpoth N, Wustmann K, Noveanu M, Gertsch M. QR in V1 – an ECG sign associated with right ventricular strain and adverse clinical outcome in pulmonary embolism. Eur Heart J 2003; 24(12): 1113-9.
[http://dx.doi.org/10.1016/S0195-668X(03)00132-5] [PMID: 12804925]
[11]
Poelzl G, Ess M, Mussner-Seeber C, Pachinger O, Frick M, Ulmer H. Liver dysfunction in chronic heart failure: Prevalence, characteristics and prognostic significance. Eur J Clin Invest 2012; 42(2): 153-63.
[http://dx.doi.org/10.1111/j.1365-2362.2011.02573.x] [PMID: 21806605]
[12]
Samsky MD, Patel CB, DeWald TA, et al. Cardiohepatic interactions in heart failure: An overview and clinical implications. J Am Coll Cardiol 2013; 61(24): 2397-405.
[http://dx.doi.org/10.1016/j.jacc.2013.03.042] [PMID: 23603231]
[13]
Hernández G, Ospina-Tascón GA, Damiani LP, et al. Effect of a resuscitation strategy targeting peripheral perfusion status vs serum lactate levels on 28-day mortality among patients with septic shock. JAMA 2019; 321(7): 654-64.
[http://dx.doi.org/10.1001/jama.2019.0071] [PMID: 30772908]
[14]
Benza RL, Gomberg-Maitland M, Elliott CG, et al. Predicting survival in patients with pulmonary arterial hypertension. Chest 2019; 156(2): 323-37.
[http://dx.doi.org/10.1016/j.chest.2019.02.004] [PMID: 30772387]
[15]
López-Candales A, Bazaz R, Edelman K, Gulyasy B. Apical systolic eccentricity index: A better marker of right ventricular compromise in pulmonary hypertension. Echocardiography 2010; 27(5): 534-8.
[http://dx.doi.org/10.1111/j.1540-8175.2009.01045.x] [PMID: 20345450]
[16]
Ghio S, Klersy C, Magrini G, et al. Prognostic relevance of the echocardiographic assessment of right ventricular function in patients with idiopathic pulmonary arterial hypertension. Int J Cardiol 2010; 140(3): 272-8.
[http://dx.doi.org/10.1016/j.ijcard.2008.11.051] [PMID: 19070379]
[17]
Maron BA, Kovacs G, Vaidya A, et al. Cardiopulmonary Hemodynamics in Pulmonary Hypertension and Heart Failure. J Am Coll Cardiol 2020; 76(22): 2671-81.
[http://dx.doi.org/10.1016/j.jacc.2020.10.007] [PMID: 33243385]
[18]
Drazner MH, Hamilton MA, Fonarow G, Creaser J, Flavell C, Warner Stevenson L. Relationship between right and left-sided filling pressures in 1000 patients with advanced heart failure. J Heart Lung Transplant 1999; 18(11): 1126-32.
[http://dx.doi.org/10.1016/S1053-2498(99)00070-4] [PMID: 10598737]
[19]
Weatherald J, Boucly A, Chemla D, et al. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension. Circulation 2018; 137(7): 693-704.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.117.029254] [PMID: 29070502]
[20]
Ranka S, Mastoris I, Kapur NK, et al. Right heart catheterization in cardiogenic shock is associated with improved outcomes: insights from the nationwide readmissions database. J Am Heart Assoc 2021; 10(17): e019843.
[http://dx.doi.org/10.1161/JAHA.120.019843] [PMID: 34423652]
[21]
Testani JM, Chen J, McCauley BD, Kimmel SE, Shannon RP. Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation 2010; 122(3): 265-72.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.109.933275] [PMID: 20606118]
[22]
Gibbons Kroeker CA, Adeeb S, Shrive NG, Tyberg JV. Compression induced by RV pressure overload decreases regional coronary blood flow in anesthetized dogs. Am J Physiol Heart Circ Physiol 2006; 290(6): H2432-8.
[http://dx.doi.org/10.1152/ajpheart.01140.2005] [PMID: 16428352]
[23]
Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol 2009; 53(7): 582-8.
[http://dx.doi.org/10.1016/j.jacc.2008.08.080] [PMID: 19215832]
[24]
Bart BA, Goldsmith SR, Lee KL, et al. Cardiorenal rescue study in acute decompensated heart failure: Rationale and design of CARRESS-HF, for the heart failure clinical research network. J Card Fail 2012; 18(3): 176-82.
[http://dx.doi.org/10.1016/j.cardfail.2011.12.009] [PMID: 22385937]
[25]
Mullens W, Damman K, Harjola VP, et al. The use of diuretics in heart failure with congestion — a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2019; 21(2): 137-55.
[http://dx.doi.org/10.1002/ejhf.1369] [PMID: 30600580]
[26]
Marenzi G, Lauri G, Grazi M, Assanelli E, Campodonico J, Agostoni P. Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol 2001; 38(4): 963-8.
[http://dx.doi.org/10.1016/S0735-1097(01)01479-6] [PMID: 11583865]
[27]
Wanamaker B, Cascino T, McLaughlin V, Oral H, Latchamsetty R, Siontis KC. Atrial arrhythmias in pulmonary hypertension: Pathogenesis, Prognosis and management. Arrhythm Electrophysiol Rev 2018; 7(1): 43-8.
[http://dx.doi.org/10.15420/aer.2018.3.2] [PMID: 29636972]
[28]
Mercurio V, Peloquin G, Bourji KI, et al. Pulmonary arterial hypertension and atrial arrhythmias: Incidence, risk factors, and clinical impact. Pulm Circ 2018; 8(2): 1-8.
[http://dx.doi.org/10.1177/2045894018769874] [PMID: 29575972]
[29]
Alajaji W, Baydoun A, Al-Kindi SG, Henry L, Hanna MA, Oliveira GH. Digoxin therapy for cor pulmonale: A systematic review. Int J Cardiol 2016; 223: 320-4.
[http://dx.doi.org/10.1016/j.ijcard.2016.08.018] [PMID: 27543702]
[30]
Markey GC, Salter N, Ryan J. Intravenous flecainide for emergency department management of acute atrial fibrillation. J Emerg Med 2018; 54(3): 320-7.
[http://dx.doi.org/10.1016/j.jemermed.2017.11.016] [PMID: 29269083]
[31]
Inami T, Kataoka M, Ishiguro H, et al. Percutaneous transluminal pulmonary angioplasty for chronic thromboembolic pulmonary hypertension with severe right heart failure. Am J Respir Crit Care Med 2014; 189(11): 1437-9.
[http://dx.doi.org/10.1164/rccm.201312-2254LE] [PMID: 24881941]
[32]
Kommireddy S, Bhyravavajhala S, Kurimeti K, et al. Pulmonary arterial hypertension in systemic lupus erythematosus may benefit by addition of immunosuppression to vasodilator therapy: An observational study. Rheumatology (Oxford) 2015; 54(9): 1673-9.
[http://dx.doi.org/10.1093/rheumatology/kev097] [PMID: 25929760]
[33]
Jais X, Launay D, Yaici A, et al. Immunosuppressive therapy in lupus- and mixed connective tissue disease–associated pulmonary arterial hypertension: A retrospective analysis of twenty-three cases. Arthritis Rheum 2008; 58(2): 521-31.
[http://dx.doi.org/10.1002/art.23303] [PMID: 18240255]
[34]
Sanges S, Savale L, Lamblin N, Rémy-Jardin M, Humbert M, Sobanski V. Efficacy of immunosuppressants with bridge vasodilator therapy in severe lupus erythematosus -associated pulmonary arterial hypertension. ESC Heart Fail 2019; 6(6): 1322-5.
[http://dx.doi.org/10.1002/ehf2.12507] [PMID: 31536678]
[35]
Kapur NK, Esposito ML, Bader Y, et al. Mechanical circulatory support devices for acute right ventricular failure. Circulation 2017; 136(3): 314-26.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.116.025290] [PMID: 28716832]
[36]
Green EM, Givertz MM. Management of acute right ventricular failure in the intensive care unit. Curr Heart Fail Rep 2012; 9(3): 228-35.
[http://dx.doi.org/10.1007/s11897-012-0104-x] [PMID: 22805893]
[37]
Hansen MS, Andersen A, Nielsen-Kudsk JE. Levosimendan in pulmonary hypertension and right heart failure. Pulm Circ 2018; 8(3): 1-7.
[http://dx.doi.org/10.1177/2045894018790905] [PMID: 29979110]
[38]
Rissel R, Gosling M, Kamuf J, et al. Levosimendan ameliorates cardiopulmonary function but not inflammatory response in a dual model of experimental ARDS. Biomedicines 2022; 10(5): 1031.
[http://dx.doi.org/10.3390/biomedicines10051031] [PMID: 35625767]
[39]
Kerbaul F, Rondelet B, Demester JP, et al. Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure. Crit Care Med 2006; 34(11): 2814-9.
[http://dx.doi.org/10.1097/01.CCM.0000242157.19347.50] [PMID: 16971854]
[40]
Ghignone M, Girling L, Prewitt RM. Volume expansion versus norepinephrine in treatment of a low cardiac output complicating an acute increase in right ventricular afterload in dogs. Anesthesiology 1984; 60(2): 132-5.
[http://dx.doi.org/10.1097/00000542-198402000-00009] [PMID: 6198941]
[41]
Hirsch LJ, Rooney MW, Wat SS, Kleinmann B, Mathru M. Norepinephrine and phenylephrine effects on right ventricular function in experimental canine pulmonary embolism. Chest 1991; 100(3): 796-801.
[http://dx.doi.org/10.1378/chest.100.3.796] [PMID: 1889275]
[42]
Kwak YL, Lee CS, Park YH, Hong YW. The effect of phenylephrine and norepinephrine in patients with chronic pulmonary hypertension*. Anaesthesia 2002; 57(1): 9-14.
[http://dx.doi.org/10.1046/j.1365-2044.2002.02324.x] [PMID: 11843735]
[43]
Tayama E, Ueda T, Shojima T, et al. Arginine vasopressin is an ideal drug after cardiac surgery for the management of low systemic vascular resistant hypotension concomitant with pulmonary hypertension. Interact Cardiovasc Thorac Surg 2007; 6(6): 715-9.
[http://dx.doi.org/10.1510/icvts.2007.159624] [PMID: 17704123]
[44]
Edwards RM, Trizna W, Kinter LB. Renal microvascular effects of vasopressin and vasopressin antagonists. Am J Physiol 1989; 256(2 Pt 2): F274-8.
[PMID: 2916660]
[45]
Price LC, Wort SJ, Finney SJ, Marino PS, Brett SJ. Pulmonary vascular and right ventricular dysfunction in adult critical care: Current and emerging options for management: A systematic literature review. Crit Care 2010; 14(5): R169.
[http://dx.doi.org/10.1186/cc9264] [PMID: 20858239]
[46]
McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2021; 42(36): 3599-726.
[http://dx.doi.org/10.1093/eurheartj/ehab368] [PMID: 34447992]
[47]
Mebazaa A, Motiejunaite J, Gayat E, et al. Long-term safety of intravenous cardiovascular agents in acute heart failure: Results from the European Society of Cardiology Heart Failure Long-Term Registry. Eur J Heart Fail 2018; 20(2): 332-41.
[http://dx.doi.org/10.1002/ejhf.991] [PMID: 28990358]
[48]
Maack C, Eschenhagen T, Hamdani N, et al. Treatments targeting inotropy. Eur Heart J 2019; 40(44): 3626-44.
[http://dx.doi.org/10.1093/eurheartj/ehy600] [PMID: 30295807]
[49]
Ostadal P, Rokyta R, Karasek J, Kruger A, Vondrakova D, Janotka M, et al. Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: Results of the ECMO-CS randomized clinical trial. Circulation 2022.
[PMID: 36335478]
[50]
Inampudi C, Tedford RJ, Hemnes AR, et al. Treatment of right ventricular dysfunction and heart failure in pulmonary arterial hypertension. Cardiovasc Diagn Ther 2020; 10(5): 1659-74.
[http://dx.doi.org/10.21037/cdt-20-348] [PMID: 33224779]
[51]
Abrams D, Madahar P, Eckhardt CM, et al. Early mobilization during extracorporeal membrane oxygenation for cardiopulmonary failure in adults: Factors associated with intensity of treatment. Ann Am Thorac Soc 2022; 19(1): 90-8.
[http://dx.doi.org/10.1513/AnnalsATS.202102-151OC] [PMID: 34077700]
[52]
de Perrot M, Granton JT, McRae K, et al. Impact of extracorporeal life support on outcome in patients with idiopathic pulmonary arterial hypertension awaiting lung transplantation. J Heart Lung Transplant 2011; 30(9): 997-1002.
[http://dx.doi.org/10.1016/j.healun.2011.03.002] [PMID: 21489818]
[53]
Vasanthan V, Garg M, Maruyama M, Michelakis E, Freed DH, Nagendran J. Extended bridge to heart and lung transplantation using pumpless extracorporeal lung assist. Can J Cardiol 2017; 33(7): 950.e11-3.
[http://dx.doi.org/10.1016/j.cjca.2017.03.014]
[54]
Hoetzenecker K, Donahoe L, Yeung JC, et al. Extracorporeal life support as a bridge to lung transplantation–experience of a high-volume transplant center. J Thorac Cardiovasc Surg 2018; 155(3): 1316-1328.e1.
[http://dx.doi.org/10.1016/j.jtcvs.2017.09.161] [PMID: 29248282]
[55]
Verbelen T, Verhoeven J, Goda M, et al. Mechanical support of the pressure overloaded right ventricle: An acute feasibility study comparing low and high flow support. Am J Physiol Heart Circ Physiol 2015; 309(4): H615-24.
[http://dx.doi.org/10.1152/ajpheart.00246.2015] [PMID: 26071544]
[56]
Rosenzweig EB, Chicotka S, Bacchetta M. Right ventricular assist device use in ventricular failure due to pulmonary arterial hypertension: Lessons learned. J Heart Lung Transplant 2016; 35(10): 1272-4.
[http://dx.doi.org/10.1016/j.healun.2016.07.010] [PMID: 27569986]
[57]
Rajdev S, Benza R, Misra V. Use of Tandem Heart as a temporary hemodynamic support option for severe pulmonary artery hypertension complicated by cardiogenic shock. J Invasive Cardiol 2007; 19(8): E226-9.
[PMID: 17712211]
[58]
Punnoose L, Burkhoff D, Rich S, Horn EM. Right ventricular assist device in end-stage pulmonary arterial hypertension: Insights from a computational model of the cardiovascular system. Prog Cardiovasc Dis 2012; 55(2): 234-243.e2.
[http://dx.doi.org/10.1016/j.pcad.2012.07.008] [PMID: 23009919]
[59]
Anderson MB, Goldstein J, Milano C, et al. Benefits of a novel percutaneous ventricular assist device for right heart failure: The prospective RECOVER RIGHT study of the Impella RP device. J Heart Lung Transplant 2015; 34(12): 1549-60.
[http://dx.doi.org/10.1016/j.healun.2015.08.018] [PMID: 26681124]
[60]
Aggarwal V, Einhorn BN, Cohen HA. Current status of percutaneous right ventricular assist devices: First-in-man use of a novel dual lumen cannula. Catheter Cardiovasc Interv 2016; 88(3): 390-6.
[http://dx.doi.org/10.1002/ccd.26348] [PMID: 26895620]
[61]
Maschke SK, Schoenfeld CO, Kaireit TF, et al. MRI-derived regional biventricular function in patients with chronic thromboembolic pulmonary hypertension before and after pulmonary endarterectomy. Acad Radiol 2018; 25(12): 1540-7.
[http://dx.doi.org/10.1016/j.acra.2018.04.002] [PMID: 29730148]
[62]
Gorter TM, Verschuuren EAM, van Veldhuisen DJ, et al. Right ventricular recovery after bilateral lung transplantation for pulmonary arterial hypertension†. Interact Cardiovasc Thorac Surg 2017; 24(6): 890-7.
[http://dx.doi.org/10.1093/icvts/ivx025] [PMID: 28329267]
[63]
Verbelen T, Claus P, Burkhoff D, et al. Low-flow support of the chronic pressure–overloaded right ventricle induces reversed remodeling. J Heart Lung Transplant 2018; 37(1): 151-60.
[http://dx.doi.org/10.1016/j.healun.2017.09.014] [PMID: 29056459]
[64]
ClinicalTrials.gov. Treatment of pulmonary arterial hypertension using the aria CV pulmonary hypertension system (ASPIRE PH). 2023. Available From: https://clinicaltrials.gov/ct2/show/NCT04555161
[65]
Vahdatpour CA, Ryan JJ, Zimmerman JM, et al. Advanced airway management and respiratory care in decompensated pulmonary hypertension. Heart Fail Rev 2022; 27(5): 1807-17.
[http://dx.doi.org/10.1007/s10741-021-10168-9] [PMID: 34476657]
[66]
Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996; 334(5): 296-301.
[http://dx.doi.org/10.1056/NEJM199602013340504] [PMID: 8532025]
[67]
Barnes H, Yeoh HL, Fothergill T, Burns A, Humbert M, Williams T. Prostacyclin for pulmonary arterial hypertension. Cochrane Database Syst Rev 2019; 5(5): CD012785.
[http://dx.doi.org/10.1002/14651858.CD012785.pub2]
[68]
Olschewski H, Ghofrani HA, Schmehl T, et al. Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. Ann Intern Med 2000; 132(6): 435-43.
[http://dx.doi.org/10.7326/0003-4819-132-6-200003210-00003] [PMID: 10733442]
[69]
Hoeper MM, Olschewski H, Ghofrani HA, et al. A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. J Am Coll Cardiol 2000; 35(1): 176-82.
[http://dx.doi.org/10.1016/S0735-1097(99)00494-5] [PMID: 10636277]
[70]
Hoeper MM, Benza RL, Corris P, et al. Intensive care, right ventricular support and lung transplantation in patients with pulmonary hypertension. Eur Respir J 2019; 53(1): 1801906.
[http://dx.doi.org/10.1183/13993003.01906-2018] [PMID: 30545979]
[71]
Barr ML, Kawut SM, Whelan TP, et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part IV: Recipient-related risk factors and markers. J Heart Lung Transplant 2005; 24(10): 1468-82.
[http://dx.doi.org/10.1016/j.healun.2005.02.019] [PMID: 16210118]
[72]
Arcasoy SM, Fisher A, Hachem RR, Scavuzzo M, Ware LB. Report of the ISHLT working group on primary lung graft dysfunction part V: Predictors and outcomes. J Heart Lung Transplant 2005; 24(10): 1483-8.
[http://dx.doi.org/10.1016/j.healun.2004.11.314] [PMID: 16210119]
[73]
Van Raemdonck D, Hartwig MG, Hertz MI, et al. Report of the ISHLT Working Group on primary lung graft dysfunction Part IV: Prevention and treatment: A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2017; 36(10): 1121-36.
[http://dx.doi.org/10.1016/j.healun.2017.07.013] [PMID: 28784325]
[74]
Yusen RD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second Official Adult Lung and Heart-Lung Transplantation Report—2015; Focus Theme: Early Graft Failure. J Heart Lung Transplant 2015; 34(10): 1264-77.
[http://dx.doi.org/10.1016/j.healun.2015.08.014] [PMID: 26454740]
[75]
Leard LE, Holm AM, Valapour M, et al. Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2021; 40(11): 1349-79.
[http://dx.doi.org/10.1016/j.healun.2021.07.005] [PMID: 34419372]
[76]
Ramos KJ, Harhay MO, Mulligan MS. Which shall i choose? Lung transplantation listing preference for individuals with interstitial lung disease and chronic obstructive pulmonary disease. Ann Am Thorac Soc 2019; 16(2): 193-5.
[http://dx.doi.org/10.1513/AnnalsATS.201809-633ED] [PMID: 30707065]
[77]
Koons B, Anderson MR, Smith PJ, Greenland JR, Singer JP. The intersection of aging and lung transplantation: its impact on transplant evaluation, outcomes, and clinical care. Curr Transplant Rep 2022; 9(3): 149-59.
[http://dx.doi.org/10.1007/s40472-022-00365-2] [PMID: 36341000]
[78]
Anderson MR, Easthausen I, Gallagher G, et al. Skeletal muscle adiposity and outcomes in candidates for lung transplantation: a lung transplant body composition cohort study. Thorax 2020; 75(9): 801-4.
[http://dx.doi.org/10.1136/thoraxjnl-2019-214461] [PMID: 32482837]
[79]
Schaenman JM, Diamond JM, Greenland JR, et al. Frailty and aging-associated syndromes in lung transplant candidates and recipients. Am J Transplant 2021; 21(6): 2018-24.
[http://dx.doi.org/10.1111/ajt.16439] [PMID: 33296550]
[80]
Bermudez CA, Crespo MM, Shlobin OA, et al. ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part II: Cardiac, surgical, perioperative, operative, and post-operative challenges and management statements. J Heart Lung Transplant 2021; 40(11): 1267-78.
[http://dx.doi.org/10.1016/j.healun.2021.07.016] [PMID: 34404570]
[81]
Schmid C, Philipp A, Hilker M, et al. Bridge to lung transplantation through a pulmonary artery to left atrial oxygenator circuit. Ann Thorac Surg 2008; 85(4): 1202-5.
[http://dx.doi.org/10.1016/j.athoracsur.2007.12.032] [PMID: 18355495]
[82]
Lang G, Taghavi S, Aigner C, et al. Primary lung transplantation after bridge with extracorporeal membrane oxygenation: a plea for a shift in our paradigms for indications. Transplantation 2012; 93(7): 729-36.
[http://dx.doi.org/10.1097/TP.0b013e318246f8e1] [PMID: 22415051]
[83]
Olsson KM, Simon A, Strueber M, et al. Extracorporeal membrane oxygenation in nonintubated patients as bridge to lung transplantation. Am J Transplant 2010; 10(9): 2173-8.
[http://dx.doi.org/10.1111/j.1600-6143.2010.03192.x] [PMID: 20636463]
[84]
Iacono A, Groves S, Garcia J, Griffith B. Lung transplantation following 107 days of extracorporeal membrane oxygenation. Eur J Cardiothorac Surg 2010; 37(4): 969-71.
[http://dx.doi.org/10.1016/j.ejcts.2009.09.039] [PMID: 19896387]
[85]
Rehder KJ, Turner DA, Hartwig MG, et al. Active rehabilitation during extracorporeal membrane oxygenation as a bridge to lung transplantation. Respir Care 2013; 58(8): 1291-8.
[http://dx.doi.org/10.4187/respcare.02155] [PMID: 23232742]
[86]
Mercier O, De Perrot M, Granton J. Management of severe pulmonary arterial hypertension. Semin Respir Crit Care Med 2013; 34(5): 700-13.
[http://dx.doi.org/10.1055/s-0033-1356460] [PMID: 24037636]
[87]
Starke H, von Dossow V, Karsten J. Intraoperative circulatory support in lung transplantation: Current trend and its evidence. Life (Basel) 2022; 12(7): 1005.
[http://dx.doi.org/10.3390/life12071005] [PMID: 35888094]
[88]
Jeon K. Critical care management following lung transplantation. Journal of Chest Surgery 2022; 55(4): 325-31.
[http://dx.doi.org/10.5090/jcs.22.067] [PMID: 35924541]
[89]
Katz WE, Gasior TA, Quinlan JJ, et al. Immediate effects of lung transplantation on right ventricular morphology and function in patients with variable degrees of pulmonary hypertension. J Am Coll Cardiol 1996; 27(2): 384-91.
[http://dx.doi.org/10.1016/0735-1097(95)00502-1] [PMID: 8557910]
[90]
Porteous MK, Ky B, Kirkpatrick JN, et al. Diastolic dysfunction increases the risk of primary graft dysfunction after lung transplant. Am J Respir Crit Care Med 2016; 193(12): 1392-400.
[http://dx.doi.org/10.1164/rccm.201508-1522OC] [PMID: 26745666]
[91]
Tudorache I, Sommer W, Kühn C, et al. Lung transplantation for severe pulmonary hypertension--awake extracorporeal membrane oxygenation for postoperative left ventricular remodelling. Transplantation 2015; 99(2): 451-8.
[http://dx.doi.org/10.1097/TP.0000000000000348] [PMID: 25119128]
[92]
Moser B, Jaksch P, Taghavi S, et al. Lung transplantation for idiopathic pulmonary arterial hypertension on intraoperative and postoperatively prolonged extracorporeal membrane oxygenation provides optimally controlled reperfusion and excellent outcome. Eur J Cardiothorac Surg 2018; 53(1): 178-85.
[http://dx.doi.org/10.1093/ejcts/ezx212] [PMID: 28950326]
[93]
Kuwana M, Watanabe H, Matsuoka N, Sugiyama N. Pulmonary arterial hypertension associated with connective tissue disease: Meta-analysis of clinical trials. BMJ Open 2013; 3(8): e003113.
[http://dx.doi.org/10.1136/bmjopen-2013-003113] [PMID: 23906950]
[94]
Zanatta E, Polito P, Famoso G, et al. Pulmonary arterial hypertension in connective tissue disorders: Pathophysiology and treatment. Exp Biol Med (Maywood) 2019; 244(2): 120-31.
[http://dx.doi.org/10.1177/1535370218824101] [PMID: 30669861]
[95]
Cavagna L, Codullo V, Ghio S, et al. Undiagnosed connective tissue diseases. Medicine (Baltimore) 2016; 95(39): e4827.
[http://dx.doi.org/10.1097/MD.0000000000004827] [PMID: 27684814]
[96]
Naranjo M, Mercurio V, Hassan H, et al. Causes and outcomes of ICU hospitalisations in patients with pulmonary arterial hypertension. ERJ Open Res 2022; 8(2): 00002-2022.
[http://dx.doi.org/10.1183/23120541.00002-2022] [PMID: 35586454]
[97]
Condliffe R, Howard LS. Connective tissue disease-associated pulmonary arterial hypertension. F1000Prime Rep 2015; 7: 06.
[98]
Fayed H, Coghlan JG. Pulmonary hypertension associated with connective tissue disease. Semin Respir Crit Care Med 2019; 40(2): 173-83.
[http://dx.doi.org/10.1055/s-0039-1685214] [PMID: 31137058]
[99]
Le Pavec J, Girgis RE, Lechtzin N, et al. Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: Impact of pulmonary arterial hypertension therapies. Arthritis Rheum 2011; 63(8): 2456-64.
[http://dx.doi.org/10.1002/art.30423] [PMID: 21538327]
[100]
Launay D, Humbert M, Berezne A, et al. Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease. Chest 2011; 140(4): 1016-24.
[http://dx.doi.org/10.1378/chest.10-2473] [PMID: 21474572]
[101]
Chauvelot L, Gamondes D, Berthiller J, et al. Hemodynamic response to treatment and outcomes in pulmonary hypertension associated with interstitial lung disease versus pulmonary arterial hypertension in systemic sclerosis: Data from a study identifying prognostic factors in pulmonary hypertension associated with interstitial lung disease. Arthritis Rheumatol 2021; 73(2): 295-304.
[http://dx.doi.org/10.1002/art.41512] [PMID: 32892515]
[102]
Crespo MM, Lease ED, Sole A, et al. ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part I: Epidemiology, assessment of extrapulmonary conditions, candidate evaluation, selection criteria, and pathology statements. J Heart Lung Transplant 2021; 40(11): 1251-66.
[http://dx.doi.org/10.1016/j.healun.2021.07.014] [PMID: 34417111]
[103]
Crespo MM, Claridge T, Domsic RT, et al. ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part III: Pharmacology, medical and surgical management of post-transplant extrapulmonary conditions statements. J Heart Lung Transplant 2021; 40(11): 1279-300.
[http://dx.doi.org/10.1016/j.healun.2021.07.013] [PMID: 34474940]
[104]
Schachna L, Medsger TA Jr, Dauber JH, et al. Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension. Arthritis Rheum 2006; 54(12): 3954-61.
[http://dx.doi.org/10.1002/art.22264] [PMID: 17133609]
[105]
Saggar R, Khanna D, Furst DE, et al. Systemic sclerosis and bilateral lung transplantation: A single centre experience. Eur Respir J 2010; 36(4): 893-900.
[http://dx.doi.org/10.1183/09031936.00139809] [PMID: 20351032]
[106]
Fernández-Codina A, Berastegui C, Pinal-Fernández I, et al. Lung transplantation in systemic sclerosis: A single center cohort study. Joint Bone Spine 2018; 85(1): 79-84.
[http://dx.doi.org/10.1016/j.jbspin.2017.03.012] [PMID: 28408277]
[107]
Paik JJ, Hirpara R, Heller JA, Hummers LK, Wigley FM, Shah AA. Thrombotic complications after radial arterial line placement in systemic sclerosis: A case series. Semin Arthritis Rheum 2016; 46(2): 196-9.
[http://dx.doi.org/10.1016/j.semarthrit.2016.03.015] [PMID: 27139167]
[108]
Uras C, Mastroeni S, Tabolli S, et al. A comparison between two educational methods in the rehabilitation of the microstomia in systemic sclerosis: A randomized controlled trial. Clin Rehabil 2019; 33(11): 1747-56.
[http://dx.doi.org/10.1177/0269215519858395] [PMID: 31216880]
[109]
Machuca TN, Collaud S, Mercier O, et al. Outcomes of intraoperative extracorporeal membrane oxygenation versus cardiopulmonary bypass for lung transplantation. J Thorac Cardiovasc Surg 2015; 149(4): 1152-7.
[http://dx.doi.org/10.1016/j.jtcvs.2014.11.039] [PMID: 25583107]
[110]
Winter H, Müller H-H, Meiser B, et al. The Munich Lung Transplant Group: Intraoperative Extracorporeal Circulation in Lung Transplantation. Thorac Cardiovasc Surg 2015; 63(8): 706-14.
[http://dx.doi.org/10.1055/s-0035-1556873] [PMID: 26291747]
[111]
Reck dos Santos P, D’Cunha J. Intraoperative support during lung transplantation. J Thorac Dis 2021; 13(11): 6576-86.
[http://dx.doi.org/10.21037/jtd-21-1166] [PMID: 34992836]
[112]
Khan MS, Memon MM, Amin E, et al. Use of balloon atrial septostomy in patients with advanced pulmonary arterial hypertension. Chest 2019; 156(1): 53-63.
[http://dx.doi.org/10.1016/j.chest.2019.03.003] [PMID: 30910639]
[113]
Blanc J, Vouhé P, Bonnet D. Potts shunt in patients with pulmonary hypertension. N Engl J Med 2004; 350(6): 623.
[http://dx.doi.org/10.1056/NEJM200402053500623] [PMID: 14762197]
[114]
Grady RM, Canter MW, Wan F, et al. Pulmonary-to-systemic arterial shunt to treat children with severe pulmonary hypertension. J Am Coll Cardiol 2021; 78(5): 468-77.
[http://dx.doi.org/10.1016/j.jacc.2021.05.039] [PMID: 34325836]
[115]
Tilea I, Varga A, Georgescu AM, Grigorescu BL. Critical care management of decompensated right heart failure in pulmonary arterial hypertension patients – An ongoing approach. J Crit Care Med (Targu Mures) 2021; 7(3): 170-83.
[http://dx.doi.org/10.2478/jccm-2021-0020] [PMID: 34722920]
[116]
Oldenburg O, Bartsch S, Bitter T, et al. Hypotensive effects of positive airway pressure ventilation in heart failure patients with sleep-disordered breathing. Sleep Breath 2012; 16(3): 753-7.
[http://dx.doi.org/10.1007/s11325-011-0571-4] [PMID: 21858618]
[117]
Ergan B, Nasiłowski J, Winck JC. How should we monitor patients with acute respiratory failure treated with noninvasive ventilation? Eur Respir Rev 2018; 27(148): 170101.
[http://dx.doi.org/10.1183/16000617.0101-2017] [PMID: 29653949]
[118]
Hong AW, Toppen W, Lee J, Wilhalme H, Saggar R, Barjaktarevic IZ. Outcomes and prognostic factors of pulmonary hypertension patients undergoing emergent endotracheal intubation. J Intensive Care Med 2023; 38(3): 280-9.
[http://dx.doi.org/10.1177/08850666221118839] [PMID: 35934945]
[119]
Ouédraogo N, Mounkaïla B, Crevel H, Marthan R, Roux E. Effect of propofol and etomidate on normoxic and chronically hypoxic pulmonary artery. BMC Anesthesiol 2006; 6(1): 2.
[http://dx.doi.org/10.1186/1471-2253-6-2] [PMID: 16515695]
[120]
Gordon C, Collard CD, Pan W. Intraoperative management of pulmonary hypertension and associated right heart failure. Curr Opin Anaesthesiol 2010; 23(1): 49-56.
[http://dx.doi.org/10.1097/ACO.0b013e3283346c51] [PMID: 19907315]
[121]
Williams GD, Philip BM, Chu LF, et al. Ketamine does not increase pulmonary vascular resistance in children with pulmonary hypertension undergoing sevoflurane anesthesia and spontaneous ventilation. Anesth Analg 2007; 105(6): 1578-84.
[http://dx.doi.org/10.1213/01.ane.0000287656.29064.89] [PMID: 18042853]
[122]
Huynh TN, Weigt SS, Sugar CA, Shapiro S, Kleerup EC. Prognostic factors and outcomes of patients with pulmonary hypertension admitted to the intensive care unit. J Crit Care 2012; 27(6): 739.e7-739.e13.
[http://dx.doi.org/10.1016/j.jcrc.2012.08.006] [PMID: 23089677]
[123]
Garcia MVF, Souza R, Costa ELV, Fernandes CJCS, Jardim CVP, Caruso P. Outcomes and prognostic factors of decompensated pulmonary hypertension in the intensive care unit. Respir Med 2021; 190: 106685.
[http://dx.doi.org/10.1016/j.rmed.2021.106685] [PMID: 34823189]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy